The role of atrial fibrillation catheter ablation in patients with heart failure

Michael L Bernard; Francis Benn; Cody M Williams; A Elise Hiltbold; Paul A Rogers; Glenn M Polin; Sammy Khatib; Sana M Al-Khatib; Daniel P Morin

doi:10.1016/j.pcad.2021.06.002

The role of atrial fibrillation catheter ablation in patients with heart failure

Prog Cardiovasc Dis. 2021 May-Jun:66:80-85. doi: 10.1016/j.pcad.2021.06.002.

Authors

Michael L Bernard¹, Francis Benn², Cody M Williams², A Elise Hiltbold², Paul A Rogers², Glenn M Polin², Sammy Khatib², Sana M Al-Khatib², Daniel P Morin²

Affiliations

¹ Ochsner Medical Center, New Orleans, LA, USA. Electronic address: mbernard@ochsner.org.
² Ochsner Medical Center, New Orleans, LA, USA.

PMID: 34332663
DOI: 10.1016/j.pcad.2021.06.002

Abstract

Atrial Fibrillation (AF) and heart failure (HF) with reduced ejection fraction (HFrEF) frequently coexist, resulting in significant morbidity and mortality. Therapeutic options for patients with AF and HFrEF are limited due to few antiarrhythmic drug (AAD) choices and historically equivocal effects of procedural interventions on mortality. However, recent randomized trials examining catheter ablation (CA) in AF patients with HFrEF have shown a beneficial effect on arrhythmic burden and HF symptoms, as well as an improvement in mortality. This review focuses on the role of CA for AF patients with HFrEF.

Keywords: Atrial Fibrillation; Catheter Ablation; Heart Failure with reduced Ejection Fraction.

Publication types

Review

MeSH terms

Action Potentials
Atrial Fibrillation / diagnosis
Atrial Fibrillation / mortality
Atrial Fibrillation / physiopathology
Atrial Fibrillation / therapy*
Catheter Ablation* / adverse effects
Catheter Ablation* / mortality
Heart Failure / diagnosis
Heart Failure / mortality
Heart Failure / physiopathology*
Heart Rate
Humans
Recovery of Function
Risk Assessment
Risk Factors
Stroke Volume
Treatment Outcome
Ventricular Function, Left